Screening the general population for mutations in specific genes is a more cost-effective way to detect people at risk of breast and ovarian cancers. This strategy, compared to only screening patients with a personal or family history can help prevent breast and ovarian cancers.
Current guidelines recommend that only those with a personal or family history that could indicate a greater risk of developing cancer be tested for gene mutations that can cause the disease. However, the successful use of testing for high-risk groups has led many to consider extending genetic testing for cancer to the whole population.
Ovarian Cancer
Ovarian cancer affects both the ovaries and is referred to as the ''silent killer'' as the symptoms go unnoticed until the disease advances.
Advertisement
‘Population-based testing for mutations in specific genes is cost effective and can prevent cancers and deaths than only carrying out genetic testing in those with a family history.’
Tweet it Now
Recent technological advances in genomic medicine make large-scale genetic testing possible. The new study evaluated the cost-effectiveness of screening the general population for ovarian and breast cancer genes, compared to only screening high-risk people.
It found that population-based testing for mutations in specific genes in women over 30 years old was cost-effective and prevented more cancers and deaths than only carrying out genetic testing in women whose personal or family history indicated a greater risk of developing cancer.
![Inflammatory Breast Cancer]( "Inflammatory Breast Cancer")
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and warmth of the breast skin looking like an orange peel.
Mutations that cause cancer can occur in many people with no history to indicate risk. These people are therefore not included in screening programs that target high-risk patients, and the mutations remain undetected. The researchers of the new study estimate that implementing a program to test all women over the age of 30 could result in thousands of fewer cases of ovarian and breast cancer in women in the US and UK.
"Population testing for breast and ovarian cancer gene mutations is the most cost-effective strategy which can prevent these cancers in high-risk women and save lives, said the paper's lead researcher, Ranjit Manchanda.
"Our findings support broadening genetic testing for breast and ovarian cancer genes across the entire population beyond just the current criteria based clinical approach. Falling costs of testing and technological advancements have made testing populations feasible. As knowledge and societal acceptability of this type of testing increases, it will provide new opportunities for cancer prevention and the way we deliver cancer genetic testing in health care. This approach can have important implications given the effective options that are available for ovarian and breast cancer risk management and prevention for women at increased risk."
Source: Eurekalert
Inflammatory Breast Cancer
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and warmth of the breast skin looking like an orange peel.
Advertisement
Mutations that cause cancer can occur in many people with no history to indicate risk. These people are therefore not included in screening programs that target high-risk patients, and the mutations remain undetected. The researchers of the new study estimate that implementing a program to test all women over the age of 30 could result in thousands of fewer cases of ovarian and breast cancer in women in the US and UK.
"Population testing for breast and ovarian cancer gene mutations is the most cost-effective strategy which can prevent these cancers in high-risk women and save lives, said the paper's lead researcher, Ranjit Manchanda.
"Our findings support broadening genetic testing for breast and ovarian cancer genes across the entire population beyond just the current criteria based clinical approach. Falling costs of testing and technological advancements have made testing populations feasible. As knowledge and societal acceptability of this type of testing increases, it will provide new opportunities for cancer prevention and the way we deliver cancer genetic testing in health care. This approach can have important implications given the effective options that are available for ovarian and breast cancer risk management and prevention for women at increased risk."
Source: Eurekalert
Inherited Breast Cancer Syndromes
Inherited breast cancers are caused due to mutations in genes that increase the risk of breast cancer in women.
Advertisement
 Breast Cancer Management: AdvancesThe crab that invades the breast is no more a fear factor with all the advancements that medical science and customized protocols can fight breast cancer. the recent developments in the management of breast cancer. | Advertisement
|
Advertisement
Recommended Readings
Latest Women Health News
Cardiovascular rehabilitation, which lowers mortality and readmission rates, is underutilized and less effective in women than in men.
Laser speckle wearable gadget helps in the early detection of postpartum hemorrhage, potentially reducing maternal mortality rates.
More than 90% of previously unexplained pregnancy losses or miscarriages were accurately determined by placental testing.
Fetal growth restriction impacts around 60,000 infants annually in Europe and the United States.
For women under 40, trying to conceive, timing intercourse around the fertile period using a urine ovulation test increases the chances of pregnancy.
